基于指南治疗天疱疮:84例单中心经验结果
本研究回顾性分析了84例日本中重度天疱疮患者,按2010年日本天疱疮管理指南治疗并随访超过2年。83例(98.8%)达到最小治疗下的完全缓解,平均缓解时间13.9±9.4个月;67例(79.8%)出现不良事件,1例(1.2%)死亡。结论提示老年及需额外治疗者不良事件风险更高,应密切监测。
要点
- 基于日本指南治疗天疱疮,98.8%患者达到最小治疗下完全缓解。
- 79.8%患者出现不良事件,以肝酶升高、感染和糖尿病为主。
- 老年及需额外治疗者不良事件风险更高,应密切监测。
核心结论
- 基于日本指南治疗中重度天疱疮可获得高缓解率,但不良事件常见。
- 老年和需额外治疗的患者不良事件风险更高,包括严重感染,应密切监测。
研究设计与样本
- 单中心回顾性研究,纳入84例日本中重度天疱疮患者。
- 患者初始按日本天疱疮管理指南治疗,随访超过2年。
- 典型治疗为泼尼松0.5-1 mg/kg/天联合硫唑嘌呤100 mg/天作为保类固醇药物。
主要发现
- 84例中83例(98.8%)达到最小治疗下完全缓解(泼尼松≤10 mg/天并联合免疫抑制剂)。
- 从治疗开始到缓解的时间为13.9±9.4个月,78例(92.9%)在2年随访内达到缓解。
- 32例(38.1%)为难治性疾病,接受了额外治疗。
- 12例(14.3%)复发,其中6例在泼尼松减量期间、6例在达到缓解后。
- 67例(79.8%)发生不良事件,主要为肝酶升高、感染和糖尿病;1例(1.2%)死于胃肠道出血。
临床怎么用
- 对中重度天疱疮可参照日本指南采用泼尼松联合硫唑嘌呤方案治疗。
- 应特别关注老年及需额外治疗患者的不良事件,包括严重感染。
局限性
- 单中心回顾性研究,样本量84例,结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Japanese guidelines for the management of pemphigus (JG) were published in 2010. However, further progress in the treatment of pemphigus requires their validation. OBJECTIVES: To examine the efficacy and safety of treatments based on the JG. METHODS: A retrospective study of 84 Japanese patients with moderate to severe pemphigus, who were initially treated in accordance with the JG and then followed up for >2 years, was performed in a single centre. Treatment typically consisted of 0.5-1 mg prednisone (PSL)/kg/day accompanied by 100 mg azathioprine/day as a steroid-sparing agent. RESULTS: In 83 of the 84 patients (98.8%), complete remission on minimal therapy (≤10 mg PSL/day and concomitant immunosuppressive agent) was achieved. The time between initiation of therapy and remission was 13.9 ± 9.4 months. In 78 patients (92.9%), remission was accomplished within the 2-year follow-up. The 32 patients with recalcitrant disease (38.1%) received additional treatment. Relapse occurred in 12 patients (14.3%) either during tapering of the PSL dose (six patients) or after achieving remission (six patients). Adverse events, mostly liver enzyme elevation, infections and diabetes, occurred in 67 patients (79.8%). One patient (1.2%) died during the observation period after gastrointestinal haemorrhage. CONCLUSIONS: Our results suggested that the elderly and patients requiring additional therapies were at higher risk of adverse events, including severe infections, and should thus be monitored carefully. This study provided clinical data that could inform revised guidelines and contribute to the evaluation of future novel therapies.
引用
- Kakuta R, Kurihara Y, Yamagami J, et al. Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases. J Eur Acad Dermatol Venereol. 2020. PMID: 31923338. doi:10.1111/jdv.16188
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。